Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Personalis, Inc. (PSNL)  
$6.56 0.02 (0.3%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 88,330,000
Market Cap: 579.44(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.17 - $6.64
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Personalis provides genetic tests for cancer. Co. also provides sequencing and data analysis services to support population sequencing initiatives. Co. operates and manages its business as one reportable operating segment, which is the sale of sequencing and data analysis services. Co.'s products include NeXT Platform, which is a platform that enable the analysis of both a tumor and its microenvironment from a single sample. Co. has created an ecosystem of products and capabilities built on the NeXT Platform: ImmunoID Next (tumor profiling from tissue), NeXT Liquid Biopsy (tumor profiling from plasma) and NeXT Personal (liquid biopsy providing for personalized tumor tracking for patients).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 3,500,000 3,510,000
Total Buy Value $0 $0 $17,745,000 $17,761,700
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 1 2
Total Shares Sold 3,876 5,103 49,945 91,614
Total Sell Value $19,186 $26,290 $237,644 $294,660
Total People Sold 3 3 4 4
Total Sell Transactions 3 5 14 31
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 220
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Chen Richard CHIEF MEDICAL OFFICER AND EVP   •       –      –    2025-05-16 4 S $4.95 $4,505 D/D (910) 124,957 -33%     
   Moore Stephen Michael SVP and Chief Legal Officer   •       –      –    2025-05-16 4 S $4.95 $8,291 D/D (1,675) 64,200 -33%     
   Tachibana Aaron CFO AND COO   •       –      –    2025-05-16 4 S $4.95 $6,390 D/D (1,291) 165,099 -33%     
   Tachibana Aaron CFO AND COO   •       –      –    2025-01-28 4 S $5.79 $4,099 D/D (708) 166,390 4%     
   Chen Richard CHIEF MEDICAL OFFICER AND EVP   •       –      –    2025-01-28 4 S $5.79 $3,005 D/D (519) 123,367 4%     
   Merck & Co Inc 10% Owner   –       –       •   2024-12-19 3 IO $0.00 $0 I/I 0 14,044,943 -21%     
   Moore Stephen Michael SVP and Chief Legal Officer   •       –      –    2024-12-16 4 S $3.82 $5,780 D/D (1,513) 65,875 -2%     
   Tachibana Aaron CFO AND COO   •       –      –    2024-12-16 4 S $3.82 $26,224 D/D (6,865) 167,098 -2%     
   Chen Richard CHIEF MEDICAL OFFICER AND EVP   •       –      –    2024-12-16 4 S $3.82 $18,466 D/D (4,834) 123,886 -2%     
   Moore Stephen Michael SVP and Chief Legal Officer   •       –      –    2024-11-18 4 S $3.79 $6,416 D/D (1,693) 67,388 4%     
   Tachibana Aaron CFO AND COO   •       –      –    2024-11-18 4 S $3.79 $4,954 D/D (1,307) 173,963 4%     
   Chen Richard CHIEF MEDICAL OFFICER AND EVP   •       –      –    2024-11-18 4 S $3.79 $3,491 D/D (921) 128,720 4%     
   Hall Christopher M PRESIDENT AND CEO   •       •      –    2024-11-01 4 S $5.38 $142,263 D/D (26,443) 178,098 25%     
   Tempus Labs, Inc. 10% Owner   –       –       •   2024-08-16 4 B $5.07 $17,745,000 D/D 3,500,000 12,718,800 2.45 2%     
   Tempus Labs, Inc. 10% Owner   –       –       •   2024-08-16 4 OE $1.50 $18,437,600 D/D 9,218,800 9,218,800     -
   Chen Richard CHIEF MEDICAL OFFICER AND EVP   •       –      –    2024-07-30 4 S $2.97 $1,556 D/D (524) 127,227 -33%     
   Tachibana Aaron CFO AND COO   •       –      –    2024-07-30 4 S $2.97 $2,204 D/D (742) 175,270 -33%     
   Chen Richard CHIEF MEDICAL OFFICER AND EVP   •       –      –    2024-06-17 4 S $1.29 $6,521 D/D (5,055) 127,751 -267%     
   Moore Stephen Michael SVP and Chief Legal Officer   •       –      –    2024-06-17 4 S $1.29 $2,045 D/D (1,585) 69,081 -267%     
   Tachibana Aaron CFO AND COO   •       –      –    2024-06-17 4 S $1.29 $9,257 D/D (7,176) 176,012 -267%     
   Tachibana Aaron CFO AND COO   •       –      –    2024-05-17 4 S $1.38 $1,840 D/D (1,333) 183,188 -273%     
   Chen Richard CHIEF MEDICAL OFFICER AND EVP   •       –      –    2024-05-17 4 S $1.38 $1,297 D/D (940) 132,806 -273%     
   Moore Stephen Michael SVP and Chief Legal Officer   •       –      –    2024-05-17 4 S $1.38 $2,389 D/D (1,731) 70,666 -273%     
   Moore Stephen Michael SVP and Chief Legal Officer   •       –      –    2024-04-30 4 S $1.37 $6,197 D/D (4,523) 72,397 -293%     
   Myers Woodrow A Jr   –       •      –    2024-03-01 4 B $1.67 $16,700 D/D 10,000 26,116 0.01 -2%     
  220 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us